Non-surgical management of advanced ovarian cancer with maintenance PARP inhibitors

Non-surgical management of advanced ovarian cancer with maintenance PARP inhibitors

The standard of care for advanced ovarian cancer is cytoreductive surgery followed by a platinum-taxane combination with PARP inhibition as a maintenance strategy. In practice, many advanced ovarian cancer patients are older and are either not candidates for surgery or decline surgical intervention....

Full description

Bibliographic Details
Main Authors: Taliya Lantsman, Lily Jia, Meghan Shea
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578924000195

Similar Items

Similar Items